Global Vendor Neutral Archive (VNA) Market, By Deployment Model (On-Premise VNA, Cloud-Based VNA), By Vendor Type (Independent Software Vendors (ISVs), PACS Vendors, Infrastructure Vendors), By Imaging Type (Radiology VNAs, Cardiology VNAs, Pathology VNAs
Global Vendor Neutral Archive (VNA) Market, By Deployment Model (On-Premise VNA, Cloud-Based VNA), By Vendor Type (Independent Software Vendors (ISVs), PACS Vendors, Infrastructure Vendors), By Imaging Type (Radiology VNAs, Cardiology VNAs, Pathology VNAs), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Care Centers, Research and Academic Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The global vendor neutral archive (VNA) market was valued US$ 3.96 Bn in 2023 and is expected to reach US$ 5.93 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Figure 1. Global Vendor Neutral Archive (VNA) Market Share (%), By Region, 2023
Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.
Market Dynamics:
The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.
Key features of the study:
This report provides an in-depth analysis of the global vendor neutral archive (VNA) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market
Detailed Segmentation:
Global Vendor Neutral Archive (VNA) Market, By Deployment Model
On-Premise VNA
Cloud-Based VNA
Global Vendor Neutral Archive (VNA) Market, By Vendor Type
Independent Software Vendors (ISVs)
PACS Vendors
Infrastructure Vendors
Global Vendor Neutral Archive (VNA) Market, By Imaging Type
Radiology VNAs
Cardiology VNAs
Pathology VNAs
Global Vendor Neutral Archive (VNA) Market, By End-User
Hospitals
Diagnostic Imaging Centers
Ambulatory Care Centers
Research and Academic Institutes
Global Vendor Neutral Archive (VNA) Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Global Vendor Neutral Archive (VNA) Market, Key Players
Johnson & Johnson Private Limited
Merck & Co., Inc.
F.Hoffmann-La Roche Ltd.
Baxter
Bayer AG
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lupin
Allergan
AbbVie Inc.
Abbott
Bausch Health Companies Inc.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
AstraZeneca
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Vendor Neutral Archive (VNA) Market, By Deployment Model
Global Vendor Neutral Archive (VNA) Market, By Vendor Type
Global Vendor Neutral Archive (VNA) Market, By Imaging Type
Global Vendor Neutral Archive (VNA) Market, By End User
Global Vendor Neutral Archive (VNA) Market, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing adoption of cloud-based VNA solutions
Growing adoption of imaging equipment across healthcare facilities
Impact Analysis
Key Highlights
Regulatory Scenario
Service Offering Portfolio
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Pipeline Analysis
4. Global Vendor Neutral Archive (VNA) Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
On-premise VNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cloud-based VNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
6. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Independent Software Vendors (ISVs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
PACS Vendors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Infrastructure Vendors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
7. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Radiology VNAs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cardiology VNAs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Pathology VNAs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
8. Global Vendor Neutral Archive (VNA) Market, By End User, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Diagnostic Imaging Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Ambulatory Care Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Research and Academic Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
9. Global Vendor Neutral Archive (VNA) Market, By Region, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019 – 2031
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2019-2031,(US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Johnson & Johnson Private Limited
Company Highlights
Deployment Model Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Deployment Model Portfolio
Key Highlights
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Deployment Model Portfolio
Key Highlights
Financial Performance
Strategies
Baxter
Company Highlights
Deployment Model Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lupin
Allergan
AbbVie Inc.
Abbott
Bausch Health Companies Inc.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
AstraZeneca
Analyst Views
11. Section
Research Methodology
About us
*Browse 44 market data tables and 36 figures on “Global Vendor Neutral Archive (VNA) Market” - Global forecast to 2031